Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04223102 · ClinicalTrials.gov registry record · NA
Microbiome and Rectal Cancer
A NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm, sponsored by University of South Florida.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT04223102 is a NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm that is active but no longer recruiting, run by University of South Florida. The registered enrollment target is 40 participants, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04223102, a NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm, is active but no longer recruiting, sponsored by University of South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.
Conditions Studied
Interventions
- PROCEDURE Tissue collection
Study Locations (3)
Florida
- Tampa General Hospital - Tampa
- University of South Florida - South Tampa Campus - Tampa
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04223102
The ClinicalTrials.gov registry entry for NCT04223102 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tissue collection is the first listed.
NCT04223102 reports 3 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04223102 about?
NCT04223102 is a clinical study titled "Microbiome and Rectal Cancer". The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.
What is the current status of trial NCT04223102?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-18. Estimated completion is 2027-06.
What conditions does trial NCT04223102 study?
This clinical trial studies the following conditions: Rectal Cancer, Locally Advanced Malignant Neoplasm.
What interventions are being tested in trial NCT04223102?
The interventions under investigation include: Tissue collection (PROCEDURE).
Who is sponsoring clinical trial NCT04223102?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04223102 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.